openPR Logo
Press release

Anatomic Pathology Market Set to Reach USD 73.8 Billion by 2036 as Digital Pathology and Cancer Diagnostics Transform Laboratory Workflows

05-18-2026 06:56 PM CET | Health & Medicine

Press release from: Future Market Insights Inc

Anatomic Pathology Market Set to Reach USD 73.8 Billion by 2036 as

NEWARK, Del., USA | May 18, 2026 - According to the latest analysis by Future Market Insights, the global anatomic pathology market is entering a steady expansion phase, fueled by rising cancer incidence, increasing biopsy volumes, and growing adoption of digital pathology technologies across hospital laboratories and diagnostic networks. As healthcare systems prioritize faster diagnosis, workflow efficiency, and precision medicine, anatomic pathology solutions are becoming essential for tissue-based disease diagnosis and treatment planning.

Featured Snippet: Key Market Insights

Market Size (2025): USD 42.7 Billion
• Forecast Value (2036): USD 73.8 Billion
• CAGR (2026-2036): 5.1%
• Top Growth Countries: India and China
• Key Drivers: Rising cancer testing, digital pathology adoption, automation, recurring consumable demand
• Leading Application: Disease Diagnosis
• Core Technologies: Automated systems, digital pathology platforms, tissue processing solutions

Get detailed market forecasts, competitive benchmarking, and workflow insights:
https://www.futuremarketinsights.com/reports/sample/rep-gb-12370

Market Overview: Tissue Diagnosis Remains Central to Modern Healthcare

The anatomic pathology market is projected to grow from USD 44.9 billion in 2026 to USD 73.8 billion by 2036, registering a CAGR of 5.1% during the forecast period. The market continues to benefit from the critical role pathology plays in cancer diagnosis, surgical pathology, biomarker analysis, and disease monitoring.

Anatomic pathology solutions support tissue examination workflows including sample preparation, tissue processing, staining, slide preparation, interpretation, and reporting. Hospitals and laboratories are increasingly upgrading pathology infrastructure with automation and digital imaging systems to improve turnaround time, workflow consistency, and diagnostic accuracy.

Key Market Drivers

Rising Cancer Burden and Biopsy Volumes
The growing global incidence of cancer and chronic diseases is driving demand for tissue-based diagnostics. Biopsy interpretation remains central to treatment planning across oncology and gastrointestinal disease management.

Healthcare providers are increasingly relying on:

Histopathology testing
• Immunohistochemistry analysis
• Biomarker identification
• Digital slide interpretation
This sustained testing activity is supporting long-term demand for pathology instruments, consumables, and services.

Growing Adoption of Digital Pathology
Laboratories are rapidly modernizing workflows with:

Digital slide scanners
• AI-assisted image analysis
• Cloud-based pathology review systems
• Remote collaboration platforms
Digital pathology is helping pathologists manage complex case volumes while improving workflow standardization and access to second opinions.

Automation Improves Laboratory Efficiency
Automated pathology systems are reducing manual workload while improving consistency in tissue processing and staining procedures. High-volume laboratories are increasingly adopting:

Automated staining systems
• Slide preparation technologies
• Integrated imaging workflows
• Workflow management software
These upgrades are supporting faster turnaround times and stronger quality control.

Regional Insights

North America

North America remains a mature and innovation-driven market supported by:

High cancer testing volumes
• Strong hospital laboratory infrastructure
• Early adoption of digital pathology systems
• Growing biomarker-based diagnostics
The United States continues to lead due to steady biopsy-based diagnosis and ongoing pathology workflow modernization.

India

India is projected to emerge as the fastest-growing market with a CAGR of 6.5% through 2036, driven by:

Expansion of private diagnostic chains
• Hospital infrastructure development
• Growing pathology laboratory capacity
• Rising access to biopsy-based diagnosis
Major cities are witnessing rapid investment in histopathology and digital pathology systems.

China

China is expected to expand at a CAGR of 6.1% due to:

Hospital modernization programs
• Growing cancer screening activities
• Rising tissue testing volumes
• Increasing laboratory automation adoption
Structured pathology workflows are significantly improving testing efficiency across hospital networks.

Technology Trends Shaping the Market

The anatomic pathology market is evolving through integration of advanced laboratory technologies, including:

AI-powered digital pathology platforms
• Automated tissue processing systems
• Whole-slide imaging technologies
• Remote pathology consultation tools
• Workflow optimization software
Image management and software-led pathology review are becoming critical components of modern pathology laboratories.

Challenges in the Market

Budget Constraints and Staffing Gaps

Many laboratories continue to face:

Capital approval delays
• Pathologist shortages
• High implementation costs for digital systems
• Workflow integration challenges
These factors may slow equipment replacement cycles in certain regions.

Complex Laboratory Standardization

Maintaining consistency across tissue preparation, staining quality, and reporting workflows remains a major operational challenge for high-volume laboratories.

Opportunities: AI-Driven Pathology and Workflow Modernization

The market is unlocking new growth opportunities through:

Expansion of AI-assisted pathology interpretation
• Growth in remote diagnostic services
• Increasing laboratory standardization
• Higher demand for workflow automation
• Development of integrated pathology ecosystems
Companies focusing on workflow stability, digital integration, and consumable supply reliability are expected to strengthen market positioning.

👉 Speak to Analyst: Customize insights for your business strategy:
https://www.futuremarketinsights.com/customization-available/rep-gb-12370

Segmentation Insights

Consumables Segment

Expected to account for 37.9% of the product segment in 2026
• Driven by recurring use of reagents, stains, slides, and antibodies
• Represents stable recurring revenue for suppliers
Disease Diagnosis Segment

Projected to hold 48.0% share of the application segment in 2026
• Biopsy review remains central to treatment planning
• Strong demand across oncology and gastrointestinal diseases
Automated Systems

Expected to account for 35.0% of the technology segment in 2026
• Supports faster processing and reduced manual workload
• Increasingly adopted by large hospital laboratories
Oncology Segment

Projected to account for 46.0% of disease area demand
• Cancer diagnosis remains the largest pathology application
• Biomarker-driven therapies continue to increase testing intensity
Competitive Landscape

The anatomic pathology market is moderately concentrated, with major companies competing across instruments, consumables, services, and digital workflow technologies.

Leading Companies

F. Hoffmann-La Roche Ltd - Comprehensive pathology and digital workflow portfolio
• Danaher Corporation - Strong instrument and automation capabilities
• Agilent Technologies Inc. - Advanced pathology staining and imaging systems
• Hologic Inc. - Diagnostic workflow technologies
• Labcorp - Expanding digital pathology deployment across laboratory networks
Emerging and Specialized Players

NeoGenomics
• Gestalt Diagnostics
• Inspirata Inc.
• Nichirei Bioscience
• BioGenex
These companies are investing heavily in AI-powered pathology platforms, remote review systems, and advanced workflow management technologies.

Browse Full Report Here:
https://www.futuremarketinsights.com/reports/anatomic-pathology-market

Conclusion: Digital Transformation Reshapes the Future of Pathology

The anatomic pathology market is steadily evolving into a digitally enabled, automation-driven healthcare ecosystem. Rising cancer testing demand, increasing biopsy workloads, and laboratory modernization initiatives are accelerating adoption of advanced pathology systems worldwide.

As healthcare providers continue prioritizing diagnostic accuracy, workflow efficiency, and faster clinical decision-making, anatomic pathology technologies will remain central to precision medicine and next-generation diagnostic infrastructure through 2036.

FAQs

1. How large is the anatomic pathology market in 2026?
The anatomic pathology market is expected to reach USD 44.9 billion in 2026.
2. What is the projected market value by 2036?
The market is forecast to reach USD 73.8 billion by 2036.
3. What CAGR is expected for the anatomic pathology market?
The market is projected to grow at a 5.1% CAGR from 2026 to 2036.
4. Which product segment leads the market in 2026?
Consumables lead the market with a 37.9% share in 2026 due to repeat reagent demand.
5. Which country is expected to grow the fastest in this market?
India is projected to register the fastest growth with a 6.5% CAGR through 2036.

Have a Look at Related Research Reports on the Healthcare Domain

Anatomic Pathology Track and Trace Solution Market -http://futuremarketinsights.com/reports/anatomic-pathology-track-and-trace-solution-market

Pathology Devices Market - https://www.futuremarketinsights.com/reports/pathology-devices-market

Pathology Imaging Systems Market - https://www.futuremarketinsights.com/reports/pathology-imaging-systems-market

Human Anatomical Models Market - https://www.futuremarketinsights.com/reports/human-anatomical-models-market

Digital Pathology Market -https://www.futuremarketinsights.com/reports/global-digital-pathology-market

Contact Us

Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware - 19713, USA

T: +1-347-918-3531

For Sales Enquiries: sales@futuremarketinsights.com

About Future Market Insights (FMI)

Future Market Insights is a leading provider of market intelligence and consulting services, serving clients in over 150 countries. Headquartered in Newark, with a global delivery center in Pune and offices in the United Kingdom and United Arab Emirates, FMI delivers actionable insights across industries including food & beverage, healthcare, chemicals, and consumer goods.

An ESOMAR-certified organization, FMI provides data-driven insights to support strategic decision-making for global businesses.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Anatomic Pathology Market Set to Reach USD 73.8 Billion by 2036 as Digital Pathology and Cancer Diagnostics Transform Laboratory Workflows here

News-ID: 4517335 • Views:

More Releases from Future Market Insights Inc

Gastro-retentive Drug Delivery Systems Market Set to Reach USD 51.3 Billion by 2036 as Controlled-Release Therapies and Patient-Centric Formulations Accelerate Pharmaceutical Innovation
Gastro-retentive Drug Delivery Systems Market Set to Reach USD 51.3 Billion by 2 …
NEWARK, Del., USA | May 18, 2026 - According to the latest analysis by Future Market Insights, the global Gastro-retentive Drug Delivery Systems (GRDDS) market is entering a high-growth phase, driven by increasing demand for controlled-release oral formulations, improved therapeutic efficacy, and enhanced patient compliance. Pharmaceutical manufacturers and contract development organizations are increasingly investing in advanced gastric retention technologies to improve drug bioavailability and reduce dosing frequency across gastrointestinal, diabetes,
Cane Molasses Market Transitions from Commodity Byproduct to Strategic Bioindustrial Feedstock: Why Ethanol Policies, Livestock Nutrition Demand, and Supply Volatility Are Reshaping a USD 6.5 Billion Industry
Cane Molasses Market Transitions from Commodity Byproduct to Strategic Bioindust …
The global cane molasses market is evolving from a traditional sugar-refining byproduct category into a strategically important component of biofuel production, livestock nutrition, industrial fermentation, and specialty food applications. As governments accelerate ethanol blending mandates and agricultural industries seek cost-efficient feed formulations, cane molasses is increasingly being repositioned as a multi-functional industrial feedstock with rising strategic value across global supply chains. Trade concentration, weather-driven sugar cane volatility, and premium product
Calcium Caseinate Market Evolves Beyond Traditional Dairy Proteins: Why Sports Nutrition, Clinical Nutrition, and Functional Food Reformulation Are Reshaping a USD 703.1 Million Industry
Calcium Caseinate Market Evolves Beyond Traditional Dairy Proteins: Why Sports N …
The global calcium caseinate market is transitioning from a conventional dairy protein ingredient category into a strategically important segment within premium nutrition, clinical formulation, and functional food manufacturing ecosystems. Sports nutrition brands, clinical nutrition formulators, infant nutrition manufacturers, and premium food processors are strengthening procurement of high-specification dairy proteins capable of balancing nutritional functionality, formulation stability, and scalable production efficiency, according to latest insights by future market insights. Get detailed market
Natural Tea Extract Market Evolves from Traditional Botanical Ingredient to Functional Wellness Infrastructure: Why Nutraceutical Demand, Functional Beverage Innovation, and Premium Organic Positioning Are Reshaping a USD 12.7 Billion Industry
Natural Tea Extract Market Evolves from Traditional Botanical Ingredient to Func …
The global natural tea extract market is undergoing a significant transformation from a conventional botanical ingredient category into a strategically important component of functional nutrition, wellness beverages, and plant-based health formulations. As consumers increasingly prioritize antioxidant-rich products, clean-label ingredients, and preventive wellness solutions, tea extracts are becoming deeply integrated into functional beverages, nutraceutical supplements, personal care formulations, and specialty food applications. Manufacturers are moving beyond commodity tea ingredients toward standardized,

All 5 Releases


More Releases for Pathology

[Latest] Digital Pathology Market Transforming Diagnostics with AI-Powered Solut …
"𝐈𝐧𝐧𝐨𝐯𝐚𝐭𝐢𝐯𝐞 𝐌𝐚𝐫𝐤𝐞𝐭 𝐒𝐨𝐥𝐮𝐭𝐢𝐨𝐧𝐬 𝐄𝐦𝐩𝐨𝐰𝐞𝐫𝐢𝐧𝐠 𝐁𝐮𝐬𝐢𝐧𝐞𝐬𝐬𝐞𝐬 𝐰𝐢𝐭𝐡 𝐒𝐦𝐚𝐫𝐭𝐞𝐫 𝐃𝐞𝐜𝐢𝐬𝐢𝐨𝐧𝐬" The latest study released on the Digital Pathology Market evaluates market size, trend, and forecast to 2030. The Digital Pathology market study covers significant research data and proofs to be a handy resource document for managers, analysts, industry experts and other key people to have ready-to-access and self-analyzed study to help understand market trends, growth drivers, opportunities and upcoming challenges and about the
Pathology Unveiled: Exploring the Digital Pathology Market (2023-2028)
How Big is the Digital Pathology Market ? : According to the latest report by IMARC Group, titled "Digital Pathology Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028," The global digital pathology market size reached US$ 850.2 Million in 2022. Looking forward, IMARC Group expects the market to reach US$ 1,531.1 Million by 2028, exhibiting a growth rate (CAGR) of 9.8% during 2023-2028. What is Digital Pathology ? : Digital
Revolutionizing Pathology: The Growth and Advancements of the Digital Pathology …
Digital pathology is a technology that involves digitizing glass slides of tissue samples to create high-resolution digital images that can be viewed, analyzed, and shared using a computer. Digital pathology can enhance traditional pathology workflows by providing faster, more accurate, and more efficient methods of analysis. 𝐆𝐞𝐭 𝐒𝐚𝐦𝐩𝐥𝐞 𝐑𝐞𝐩𝐨𝐫𝐭 𝐚𝐭: https://www.alliedmarketresearch.com/on-demand-updates/A01397 The process of creating digital pathology images typically involves scanning glass slides using a high-resolution digital scanner. The resulting digital images
Pathological Examination Market by Type (Traditional Pathology and Digital Patho …
According to a new report published by Allied Market Research, titled, "Pathological Examination Market: Global Opportunity Analysis and Industry Forecast, 2017-2025" The global pathological examination market share was valued to be at $171 billion in 2017 and is expected to reach $438 billion by 2025, registering a CAGR of 12.3% from 2019 to 2025. Pathology is a study that involves diagnosis of diseases through examination of bodily fluids such as
Digital Pathology Market 2023 by Key Players Analysis - Danaher Corporation, Ham …
The global digital pathology market is projected to showcase extensive growth during the forecast period, mainly due to increasing adoption of digital pathology products to improve the efficiency of laboratories across the globe, and rising government initiatives in collaboration with market players to raise awareness about the advanced digital pathology products and technologies. Browse report sample at: https://www.psmarketresearch.com/market-analysis/digital-pathology-market/report-sample Based on product, the digital pathology market is bifurcated into software, scanner, communication systems,
Digital Pathology Market: Rise in Installation of Digital Pathology Systems to B …
The global digital pathology market is expanding at a rapid pace, driven by increase in installation of digital pathology systems. The global market was valued at US$ 340 Mn in 2017 and is projected to reach more than US$ 900 Mn by 2026, expanding at a CAGR of more than 12% from 2018 to 2026. The global digital pathology market is witnessing expansion at a relatively higher growth rate owing